Benchmark Starts Ligand Pharma (LGND) at Buy
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $288.82 --0%
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 6
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 6
Join SI Premium – FREE
Benchmark analyst Robert Wasserman initiates coverage on Ligand Pharma (NASDAQ: LGND) with a Buy rating.
For an analyst ratings summary and ratings history on Ligand Pharma click here. For more ratings news on Ligand Pharma click here.
Shares of Ligand Pharma closed at $92.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
